---
annotation-target: fimmu-13-913275.pdf
---


>%%
>```annotation-json
>{"created":"2022-09-17T02:58:10.821Z","updated":"2022-09-17T02:58:10.821Z","document":{"title":"RelB contributes to the survival, migration and lymphomagenesis of B cells with constitutively active CD40 signaling","link":[{"href":"urn:x-pdf:d2651a4b81d476dcd076128a9c02ab12"},{"href":"vault:/hematology-theroy/papers/20220917/fimmu-13-913275.pdf"}],"documentFingerprint":"d2651a4b81d476dcd076128a9c02ab12"},"uri":"vault:/hematology-theroy/papers/20220917/fimmu-13-913275.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220917/fimmu-13-913275.pdf","selector":[{"type":"TextPositionSelector","start":1726,"end":2322},{"type":"TextQuoteSelector","exact":"Activation of CD40-signaling contributes to the initiation, progression and drugresistance of B cell lymphomas. We contributed to this knowledge by showingthat constitutive CD40-signaling in B cells induces B cell hyperplasia and finallyB cell lymphoma development in transgenic mice. CD40 activates, amongothers, the non-canonical NF-ĸB signaling, which is constitutively activated inseveral human B cell lymphomas and is therefore presumed to contribute tolymphopathogenesis. This prompted us to study the regulatory role of the non-canonical NF-ĸB transcription factor RelB in lymphomagenesis.","prefix":"tium (DKTK), Heidelberg, Germany","suffix":" To this end, wecrossed mice exp"}]}]}
>```
>%%
>*%%PREFIX%%tium (DKTK), Heidelberg, Germany%%HIGHLIGHT%% ==Activation of CD40-signaling contributes to the initiation, progression and drugresistance of B cell lymphomas. We contributed to this knowledge by showingthat constitutive CD40-signaling in B cells induces B cell hyperplasia and finallyB cell lymphoma development in transgenic mice. CD40 activates, amongothers, the non-canonical NF-ĸB signaling, which is constitutively activated inseveral human B cell lymphomas and is therefore presumed to contribute tolymphopathogenesis. This prompted us to study the regulatory role of the non-canonical NF-ĸB transcription factor RelB in lymphomagenesis.== %%POSTFIX%%To this end, wecrossed mice exp*
>%%LINK%%[[#^93ycihg7om|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^93ycihg7om


>%%
>```annotation-json
>{"created":"2022-09-17T02:58:48.273Z","updated":"2022-09-17T02:58:48.273Z","document":{"title":"RelB contributes to the survival, migration and lymphomagenesis of B cells with constitutively active CD40 signaling","link":[{"href":"urn:x-pdf:d2651a4b81d476dcd076128a9c02ab12"},{"href":"vault:/hematology-theroy/papers/20220917/fimmu-13-913275.pdf"}],"documentFingerprint":"d2651a4b81d476dcd076128a9c02ab12"},"uri":"vault:/hematology-theroy/papers/20220917/fimmu-13-913275.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220917/fimmu-13-913275.pdf","selector":[{"type":"TextPositionSelector","start":4537,"end":4772},{"type":"TextQuoteSelector","exact":"our data suggest thatRelB, although it is not strictly required for malignant transformation,accelerates the lymphomagenesis of long-term CD40-stimulated B cells byregulating genes involved in migration, survival and cytokine signaling","prefix":"ger latency period. In summary, ","suffix":".KEYWORDSCD40, non-canonical NF-"}]}]}
>```
>%%
>*%%PREFIX%%ger latency period. In summary,%%HIGHLIGHT%% ==our data suggest thatRelB, although it is not strictly required for malignant transformation,accelerates the lymphomagenesis of long-term CD40-stimulated B cells byregulating genes involved in migration, survival and cytokine signaling== %%POSTFIX%%.KEYWORDSCD40, non-canonical NF-*
>%%LINK%%[[#^9l6xiy9zwie|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^9l6xiy9zwie


>%%
>```annotation-json
>{"created":"2022-09-17T03:02:21.775Z","updated":"2022-09-17T03:02:21.775Z","document":{"title":"RelB contributes to the survival, migration and lymphomagenesis of B cells with constitutively active CD40 signaling","link":[{"href":"urn:x-pdf:d2651a4b81d476dcd076128a9c02ab12"},{"href":"vault:/hematology-theroy/papers/20220917/fimmu-13-913275.pdf"}],"documentFingerprint":"d2651a4b81d476dcd076128a9c02ab12"},"uri":"vault:/hematology-theroy/papers/20220917/fimmu-13-913275.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220917/fimmu-13-913275.pdf","selector":[{"type":"TextPositionSelector","start":4892,"end":6698},{"type":"TextQuoteSelector","exact":"In mammals, the Nuclear Factor (NF)-kB family consists offive proteins: RelA, c-Rel and RelB, which have a transactivationdomain, and complex with p50 or p52 to form transcriptionallyactive heterodimers in the nucleus. In resting B cells, NF-ĸBproteins are retained in the cytoplasm, and thereby remaintranscriptionally inactive. Two NF-ĸB pathways have beenidentified, designated as canonical and non-canonical.Receptors like the B-cell receptor (BCR), CD40 or Toll-likereceptors (TLRs) induce canonical NF-kB signaling byactivating the inhibitor kinase complex Ikkg/Ikka/Ikkb,resulting in phosphorylation and degradation of Ikb-aandthereby the release and translocation of RelA/p50 or c-Rel/p50heterodimers into the nucleus. Members of the Tumor NecrosisFactor Receptor (TNF-R) family, e.g. CD40 or BAFF-R,additionally activate the non-canonical NF-kB pathway bystabilizing the NF-ĸB kinase (NIK), which in turnphosphorylates Ikka, which subsequently phosphorylates thecytoplasmic p100 (NF-ĸB2). Phosphorylated p100 is cleaved top52, which is then translocated as p52/RelB heterodimer into thenucleus (1–3). RelB plays an essential role in the immune system.Disruption of the RelB locus in all cells (complete RelB-KO)results in multiorgan in flammation, disruption of splenicarchitecture, and impaired germinal center formation (4, 5).Some years ago, the B cell intrinsic function of RelB and p52 hasbeen studied by analyzing mice with conditional alleles of RelBand NF-ĸB2. A marked reduction of B cells was observed inRelB/NF-ĸB2 double-deficient mice, whereas single deletion ofRelB led to only a slight decrease of mature B cells (6).Furthermore, a germinal center specific double deletion of RelB/NF-ĸB2 resulted in the collapse of germinal center Bcells and a defect in plasma cell differentiation","prefix":"ma,migration, LILRB4Introduction","suffix":" (7). A similarphenotype was des"}]}]}
>```
>%%
>*%%PREFIX%%ma,migration, LILRB4Introduction%%HIGHLIGHT%% ==In mammals, the Nuclear Factor (NF)-kB family consists offive proteins: RelA, c-Rel and RelB, which have a transactivationdomain, and complex with p50 or p52 to form transcriptionallyactive heterodimers in the nucleus. In resting B cells, NF-ĸBproteins are retained in the cytoplasm, and thereby remaintranscriptionally inactive. Two NF-ĸB pathways have beenidentified, designated as canonical and non-canonical.Receptors like the B-cell receptor (BCR), CD40 or Toll-likereceptors (TLRs) induce canonical NF-kB signaling byactivating the inhibitor kinase complex Ikkg/Ikka/Ikkb,resulting in phosphorylation and degradation of Ikb-aandthereby the release and translocation of RelA/p50 or c-Rel/p50heterodimers into the nucleus. Members of the Tumor NecrosisFactor Receptor (TNF-R) family, e.g. CD40 or BAFF-R,additionally activate the non-canonical NF-kB pathway bystabilizing the NF-ĸB kinase (NIK), which in turnphosphorylates Ikka, which subsequently phosphorylates thecytoplasmic p100 (NF-ĸB2). Phosphorylated p100 is cleaved top52, which is then translocated as p52/RelB heterodimer into thenucleus (1–3). RelB plays an essential role in the immune system.Disruption of the RelB locus in all cells (complete RelB-KO)results in multiorgan in flammation, disruption of splenicarchitecture, and impaired germinal center formation (4, 5).Some years ago, the B cell intrinsic function of RelB and p52 hasbeen studied by analyzing mice with conditional alleles of RelBand NF-ĸB2. A marked reduction of B cells was observed inRelB/NF-ĸB2 double-deficient mice, whereas single deletion ofRelB led to only a slight decrease of mature B cells (6).Furthermore, a germinal center specific double deletion of RelB/NF-ĸB2 resulted in the collapse of germinal center Bcells and a defect in plasma cell differentiation== %%POSTFIX%%(7). A similarphenotype was des*
>%%LINK%%[[#^1mefdlynd0k|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^1mefdlynd0k


>%%
>```annotation-json
>{"created":"2022-09-17T03:03:43.489Z","updated":"2022-09-17T03:03:43.489Z","document":{"title":"RelB contributes to the survival, migration and lymphomagenesis of B cells with constitutively active CD40 signaling","link":[{"href":"urn:x-pdf:d2651a4b81d476dcd076128a9c02ab12"},{"href":"vault:/hematology-theroy/papers/20220917/fimmu-13-913275.pdf"}],"documentFingerprint":"d2651a4b81d476dcd076128a9c02ab12"},"uri":"vault:/hematology-theroy/papers/20220917/fimmu-13-913275.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220917/fimmu-13-913275.pdf","selector":[{"type":"TextPositionSelector","start":7468,"end":8180},{"type":"TextQuoteSelector","exact":"ctivation of non-canonical NF-ĸB signaling must be wellbalanced to guarantee B cell survival without inducing chronicstimulation, which might induce B cell lymphomas. Thus,constitutive activation of non-canonical NF-ĸB signaling wasobserved in various B cell lymphomas such as ChronicLymphocytic Leukemia (B-CLL), Mantle Cell Lymphoma(MCL), Diffuse Large B Cell Lymphoma (DLBCL) andHodgkin-Lymphomas (HL) (10–16). Recently, a new subset ofDLBCL has been described, characterized by RelB activation(17). Hyperactivation of non-canonical NF-kB signaling can becaused by genetic mutations in key signaling molecules (e.g.BIRC3, NIK, TRAF2 and TRAF3) (12) or through stimulationby cells of the microenvironment (18).","prefix":"pe of double deficient B cells.A","suffix":" Mouse modelsmimicking genetic a"}]}]}
>```
>%%
>*%%PREFIX%%pe of double deficient B cells.A%%HIGHLIGHT%% ==ctivation of non-canonical NF-ĸB signaling must be wellbalanced to guarantee B cell survival without inducing chronicstimulation, which might induce B cell lymphomas. Thus,constitutive activation of non-canonical NF-ĸB signaling wasobserved in various B cell lymphomas such as ChronicLymphocytic Leukemia (B-CLL), Mantle Cell Lymphoma(MCL), Diffuse Large B Cell Lymphoma (DLBCL) andHodgkin-Lymphomas (HL) (10–16). Recently, a new subset ofDLBCL has been described, characterized by RelB activation(17). Hyperactivation of non-canonical NF-kB signaling can becaused by genetic mutations in key signaling molecules (e.g.BIRC3, NIK, TRAF2 and TRAF3) (12) or through stimulationby cells of the microenvironment (18).== %%POSTFIX%%Mouse modelsmimicking genetic a*
>%%LINK%%[[#^p7j3cz6w6fj|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^p7j3cz6w6fj
